Literature DB >> 19242728

Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease.

Melania Manco1, Paolo Ciampalini, Rita DeVito, Andrea Vania, Marco Cappa, Valerio Nobili.   

Abstract

Insulin resistance may favor increased urinary albumin excretion (UAE), leading progressively to chronic kidney disease (CKD). A recent study on non-alcoholic fatty liver disease (NAFLD), a condition of insulin resistance, associated this disease with the incidence of CKD in patients with type 2 diabetes. The aim of our study was to determine whether there is an association between insulin resistance and kidney function, based on estimates of UAE and creatinine clearance in children with biopsy-proven NAFLD. Kidney function was assessed in 80 patients with NAFLD and 59 individuals of normal weight matched for age and sex. Insulin resistance was measured by means of the homeostatic model assessment-insulin resistance (HOMA-IR) and limited to NAFLD patients by using the whole-body insulin sensitivity index. The HOMA-IR was found to differ significantly between the two groups (2.69 +/- 1.7 vs. 1.05 +/- 0.45; p = 0.002), while UAE (9.02 +/- 5.8 vs. 8.0 +/- 4.3 mg/24 h; p = 0.9) and creatinine clearance (78 +/- 24 vs. 80 +/- 29 mg/min; p = 0.8) did not. We found a significant but weak inverse correlation between insulin sensitivity and creatinine clearance in NAFLD patients (r (s) = -0.25;p = 0.02). No difference was observed in kidney function between NAFLD children presenting with or without metabolic syndrome, low or normal HDL-cholesterol, and different degrees of histological liver damage (grade of steatosis >or=2, necro-inflammation, and fibrosis). Patients with hypertension had increased levels of UAE (p = 0.04). A longer exposure to insulin resistance may be required to cause the increase in urinary albumin excretion and to enable the detection of the effect of the accelerated atherogenic process most likely occurring in children with fatty liver disease. Longitudinal studies are needed to rule out any causative relationship between insulin resistance and urinary albumin excretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242728     DOI: 10.1007/s00467-009-1134-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  34 in total

Review 1.  Time to abandon microalbuminuria?

Authors:  P Ruggenenti; G Remuzzi
Journal:  Kidney Int       Date:  2006-07-26       Impact factor: 10.612

2.  Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes.

Authors:  Maike C Eppens; Maria E Craig; Janine Cusumano; Stephen Hing; Albert K F Chan; Neville J Howard; Martin Silink; Kim C Donaghue
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

3.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

4.  Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus.

Authors:  Leigh M Ettinger; Katherine Freeman; Joan R DiMartino-Nardi; Joseph T Flynn
Journal:  J Pediatr       Date:  2005-07       Impact factor: 4.406

5.  Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.

Authors:  Trevor J Orchard; Yue-Fang Chang; Robert E Ferrell; Nancy Petro; Demetrius E Ellis
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

Review 6.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

7.  Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents.

Authors:  Stephanie Nguyen; Charles McCulloch; Paul Brakeman; Anthony Portale; Chi-yuan Hsu
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

8.  The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty.

Authors:  G Dahlquist; S Rudberg
Journal:  Acta Paediatr Scand       Date:  1987-09

9.  Urinary albumin excretion rate and puberty in non-diabetic children and adolescents.

Authors:  H J Bangstad; K Dahl-Jørgensen; P Kjaersgaard; K Mevold; K F Hanssen
Journal:  Acta Paediatr       Date:  1993-10       Impact factor: 2.299

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  10 in total

1.  Liver stiffness assessed by transient elastography as a potential indicator of chronic kidney disease in patients with nonalcoholic fatty liver disease.

Authors:  Shaoyou Qin; Song Wang; Xu Wang; Jiangbin Wang
Journal:  J Clin Lab Anal       Date:  2018-09-21       Impact factor: 2.352

2.  Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.

Authors:  Ivana Mikolasevic; Sandra Milic; Sanjin Racki; Luka Zaputovic; Davor Stimac; Mladen Radic; Dean Markic; Lidija Orlic
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

3.  Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease.

Authors:  Toshifumi Yodoshi; Ana Catalina Arce-Clachar; Qin Sun; Lin Fei; Kristin Bramlage; Stavra A Xanthakos; Francisco Flores; Marialena Mouzaki
Journal:  J Pediatr       Date:  2020-05-04       Impact factor: 4.406

4.  Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort.

Authors:  Robert D Toto; Tom Greene; Lee A Hebert; Leena Hiremath; Janice P Lea; Julia B Lewis; Velvie Pogue; Mohammed Sika; Xuelei Wang
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

5.  Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease.

Authors:  Antonella Mosca; Alessandro Mantovani; Annalisa Crudele; Nadia Panera; Donatella Comparcola; Rita De Vito; Marzia Bianchi; Christopher D Byrne; Giovanni Targher; Anna Alisi
Journal:  Front Pediatr       Date:  2022-06-06       Impact factor: 3.569

Review 6.  Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect.

Authors:  Rajiv Heda; Masahiko Yazawa; Michelle Shi; Madhu Bhaskaran; Fuad Zain Aloor; Paul J Thuluvath; Sanjaya K Satapathy
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

Review 7.  Nonalcoholic fatty liver disease - A multisystem disease?

Authors:  Ivana Mikolasevic; Sandra Milic; Tamara Turk Wensveen; Ivana Grgic; Ivan Jakopcic; Davor Stimac; Felix Wensveen; Lidija Orlic
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

8.  Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in Type 2 Diabetes.

Authors:  Yu-Tao Zhan; Chuan Zhang; Li Li; Chun-Shan Bi; Xin Song; Shu-Tian Zhang
Journal:  Int J Mol Sci       Date:  2012-11-12       Impact factor: 5.923

Review 9.  Metabolic syndrome in children with chronic kidney disease and after renal transplantation.

Authors:  Mieczysław Litwin; Anna Niemirska
Journal:  Pediatr Nephrol       Date:  2013-06-13       Impact factor: 3.714

Review 10.  Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link?

Authors:  L Orlić; I Mikolasevic; Z Bagic; S Racki; D Stimac; S Milic
Journal:  Gastroenterol Res Pract       Date:  2014-03-06       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.